For years, the rabbit-owning community and veterinary professionals have been engaged in a high-stakes race against Rabbit Hemorrhagic Disease Virus Type 2 (RHDV2). As the virus established itself as an endemic threat across the United States, the primary barrier to widespread vaccination was not a lack of efficacy, but a logistical hurdle: the packaging of the vaccine itself. For a long time, the only USDA-approved…